Anzeige
Mehr »
Login
Mittwoch, 24.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 915582 | ISIN: US0234361089 | Ticker-Symbol: ADY
Frankfurt
23.04.24
08:13 Uhr
84,00 Euro
+0,50
+0,60 %
1-Jahres-Chart
AMEDISYS INC Chart 1 Jahr
5-Tage-Chart
AMEDISYS INC 5-Tage-Chart
RealtimeGeldBriefZeit
84,0086,5007:40

Aktuelle News zur AMEDISYS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
25.03.UnitedHealth deal for Amedisys likely to close despite report of DOJ scutiny - analyst15
25.03.RBC raises Amedisys stock PT to $100 on AMED deal completion confidence1
20.03.Amedisys says Oregon regulators are reviewing its $3.7B acquisition by UnitedHealth 12
20.03.Amedisys dips amid report DOJ considering lawsuit to block UnitedHealth deal6
19.03.Oregon's health authority reviewing UnitedHealth's acquisition of Amedisys2
19.03.Oregon's health authority reviews UnitedHealth's acquisition of Amedisys1
19.03.AMEDISYS INC - 8-K, Current Report1
23.02.Amedisys' (AMED) Q4 Earnings Miss Estimates, Margins Up2
22.02.AMEDISYS INC - 10-K, Annual Report1
22.02.Amedisys Non-GAAP EPS of $0.94 misses by $0.05, revenue of $570.8M misses by $0.83M1
21.02.Amedisys shares edge up on strong Q4 revenue despite EPS miss1
21.02.Amedisys, Inc.: Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results130BATON ROUGE, La., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2023. Three-Month Periods...
► Artikel lesen
21.02.AMEDISYS INC - 8-K, Current Report1
09.02.Amedisys introduces advanced molecular testing nationwide1
08.02.Amedisys, Inc.: Amedisys Offers Molecular Testing for Rapid and Accurate Infection Diagnosis217BATON ROUGE, La., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is now offering advanced molecular testing...
► Artikel lesen
24.10.23Amedisys, Inc.: Amedisys Reports Third Quarter 2023 Financial Results280BATON ROUGE, La., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2023. Three-Month Periods...
► Artikel lesen
26.07.23Amedisys, Inc.: Amedisys Reports Second Quarter 2023 Financial Results333BATON ROUGE, La., July 26, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2023. Three-Month Periods...
► Artikel lesen
26.06.23Amedisys Accepts UnitedHealth's Sweetened Offer, Scraps Option Deal466MINNETONKA (dpa-AFX) - Home health and hospice caregiver Amedisys (AMED) on Monday agreed to be acquired by UnitedHealth Group (UNH) and terminated its deal with Option Care Health (OPCH).Amedisys...
► Artikel lesen
26.06.23Amedisys Agrees To Merge With Optum In Cash Deal465WASHINGTON (dpa-AFX) - Amedisys Inc. (AMED) a provider of home health, hospice, and high-acuity care announced on Monday, that it has agreed to combine with Optum, a diversified health services...
► Artikel lesen
26.06.23Unitedhealth einigt sich mit Amedisys auf Übernahme630EDEN PRAIRIE/BATON ROUGE (dpa-AFX) - Der US-Krankenversicherer Unitedhealth setzt seine Einkaufstour unter Gesundheitsdienstleistern fort. Anfang Juni hatte die Service-Tochter Optum eine Offerte für...
► Artikel lesen
Seite:  Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1